(WSJ) – Analysis shows that 27% fewer drugs launched in Europe since Trump’s international drug-pricing policy began

The Trump administration last year came up with a plan to combat high drug prices—making European governments pay more. 

The result so far: still-high drug prices in the U.S. and fewer new drugs in Europe.  (Read More)